Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP12 | P39900 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6711347 | 1.00 | CYP2C19 (0.52) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL19134623 | 0.91 | NAAA (0.51) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11794607 | 0.89 | CYP2C19 (0.44) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11818717 | 0.89 | CYP2C19 (0.44) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11794602 | 0.89 | CYP2C19 (0.44) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11818704 | 0.89 | CYP2C19 (0.44) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL5083178 | 0.88 | NAAA (0.53) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL4202317 | 0.88 | NAAA (0.53) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11800249 | 0.87 | NAAA (0.41) | CYP2C19NAAAHTTCYP19A1EPHX1 | |
| SCHEMBL11800247 | 0.87 | NAAA (0.41) | CYP2C19NAAAHTTCYP19A1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4349881-A1 | POLYESTER MATERIAL AND POLYESTER PRODUCT, AND PREPARATION METHODS THEREFOR AND USE THEREOF | Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences (CN) | 2024-04-10 | — | — | EP | disclosed |
| US-20170216301-A1 | NOVEL BICYCLIC BROMODOMAIN INHIBITORS | ZENITH EPIGENETICS LTD. | 2017-08-03 | — | — | US | disclosed |
| US-6828464-B2 | Preparation of cyclopentenones | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | disclosed |
| US-20040102655-A1 | Preparation of cyclopentenoes | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-27 | — | — | US | disclosed |
| EP-1422212-A1 | Process for preparing cyclopentenone | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-26 | — | — | EP | disclosed |
| EP-0297447-B1 | METHOD FOR THE PREPARATION OF 2-CYCLOPENTENONES | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| EP-0297447-A2 | Method for the preparation of 2-cyclopentenones | BASF Aktiengesellschaft (DE) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102655-A1 | Preparation of cyclopentenoes | CYP17A1, CYP2F1, CYP2S1 | CYP2C19 68/4885NAAA 3308/4885HTT 3412/4885 |
| US-20170216301-A1 | NOVEL BICYCLIC BROMODOMAIN INHIBITORS | BRD4, BRD3, BRD2 | CYP2C19 4668/4885NAAA 2848/4885HTT 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.